The Global Virus Network (GVN), a coalition of leading medical virologists representing 80+ Centers of Excellence and ...

VALANX Biotech (VALANX), a biotech company developing novel technology for site-specific protein conjugation in drug ...

Gilead Sciences, Inc. will present new findings from its antiviral research and development programs at IDWeek, taking place October 19-22 in Atlanta, GA. Data from 34 presentations across HIV, ...

ASN’s Kidney Week 2025 is happening November 5-9, 2025 at the George R. Brown Convention Center in Houston, Texas.

Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral ...

Georgia Southern University's College of Science and Mathematics (COSM) has received approval to launch a Doctor of ...

The Skaggs School of Pharmacy and Pharmaceutical Sciences is proud to welcome four outstanding new clinical faculty members ...

There will be no hope of restoring political support for pandemic preparedness research, nor public acceptance of it, if virologists seek to continue under a business-as-usual model. Public inclusion ...

The groundbreaking USF Health Institute for Translational Virology and Innovation will advance cutting-edge research to combat viral and immune-related threats worldwide.

To compensate, Sarían, who is studying astronomy at Ohio State University in Columbus, is applying to more graduate schools ...

Graduate academic programs at ESF share a foundation of rigorous science and dedication to wise use of natural resources. ESF offers graduate programs at several levels, from Certificates of Advanced ...